Badgley, Phelps & Bell’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-9,055
| Closed | -$899K | – | 200 |
|
|
2019
Q3 | $899K | Hold |
9,055
| – | – | 0.05% | 120 |
|
|
2019
Q2 | $837K | Sell |
9,055
-250
| -3% | -$23.7K | 0.05% | 125 |
|
|
2019
Q1 | $878K | Buy |
9,305
+4,302
| +86% | +$376K | 0.05% | 122 |
|
|
2018
Q4 | $321K | Sell |
5,003
-163
| -3% | -$12K | 0.02% | 157 |
|
|
2018
Q3 | $462K | Sell |
5,166
-303
| -6% | -$26.8K | 0.03% | 145 |
|
|
2018
Q2 | $434K | Sell |
5,469
-7,297
| -57% | -$606K | 0.03% | 147 |
|
|
2018
Q1 | $1.14M | Sell |
12,766
-78,709
| -86% | -$7.56M | 0.08% | 114 |
|
|
2017
Q4 | $9.55M | Buy |
91,475
+4,518
| +5% | +$510K | 0.66% | 67 |
|
|
2017
Q3 | $12.7M | Sell |
86,957
-930
| -1% | -$127K | 0.94% | 26 |
|
|
2017
Q2 | $11.4M | Sell |
87,887
-888
| -1% | -$109K | 0.89% | 31 |
|
|
2017
Q1 | $11M | Buy |
88,775
+1,187
| +1% | +$142K | 0.89% | 30 |
|
|
2016
Q4 | $10.1M | Sell |
87,588
-539
| -0.6% | -$60K | 0.88% | 41 |
|
|
2016
Q3 | $9.21M | Sell |
88,127
-395
| -0.4% | -$42.8K | 0.81% | 45 |
|
|
2016
Q2 | $8.73M | Buy |
88,522
+339
| +0.4% | +$35.1K | 0.8% | 43 |
|
|
2016
Q1 | $8.83M | Buy |
88,183
+4,339
| +5% | +$447K | 0.83% | 42 |
|
|
2015
Q4 | $10M | Sell |
83,844
-445
| -0.5% | -$51.5K | 0.99% | 33 |
|
|
2015
Q3 | $9.12M | Buy |
84,289
+225
| +0.3% | +$27.9K | 0.95% | 34 |
|
|
2015
Q2 | $9.73M | Buy |
84,064
+158
| +0.2% | +$18.1K | 0.95% | 40 |
|
|
2015
Q1 | $9.67M | Sell |
83,906
-621
| -0.7% | -$74.2K | 0.95% | 40 |
|
|
2014
Q4 | $9.46M | Buy |
84,527
+192
| +0.2% | +$20.2K | 0.93% | 45 |
|
|
2014
Q3 | $7.99M | Sell |
84,335
-2,254
| -3% | -$203K | 0.79% | 57 |
|
|
2014
Q2 | $7.44M | Sell |
86,589
-1,825
| -2% | -$139K | 0.74% | 62 |
|
|
2014
Q1 | $6.17M | Buy |
88,414
+676
| +0.8% | +$53.5K | 0.64% | 71 |
|
|
2013
Q4 | $7.41M | Sell |
87,738
-340
| -0.4% | -$26.9K | 0.78% | 59 |
|
|
2013
Q3 | $6.79M | Buy |
88,078
+54
| +0.1% | +$3.78K | 0.76% | 65 |
|
|
2013
Q2 | $5.15M | Buy |
+88,024
| New | +$5.3M | 0.61% | 76 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Badgley, Phelps & Bell's CELG Position: Q4 2019 in Review
Badgley, Phelps & Bell sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,055 shares — an estimated $899K sold.
Badgley, Phelps & Bell first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $12.7M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Badgley, Phelps & Bell reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Badgley, Phelps & Bell sold 9,055 Celgene Corp shares in Q4 2019, an estimated $899K.
- Badgley, Phelps & Bell first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Badgley, Phelps & Bell's Celgene Corp position peaked at $12.7M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Badgley, Phelps & Bell's 13F filing for Q4 2019, filed 23 Jan 2020.